IVO 250 (Tibsovo 250 mg)
Generic Name: ivosidenib
Pill with imprint IVO 250 is Blue, Elliptical / Oval and has been identified as Tibsovo 250 mg. It is supplied by Agios Pharmaceuticals, Inc..
Tibsovo is used in the treatment of acute myeloid leukemia and belongs to the drug class miscellaneous antineoplastics. Tibsovo 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IVO 250
Tibsovo
- Generic Name
- ivosidenib
- Imprint
- IVO 250
- Strength
- 250 mg
- Color
- Blue
- Size
- 18.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Agios Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 71334-0100
More about Tibsovo (ivosidenib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: miscellaneous antineoplastics
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.